ADGM insider transaction filings
Adagio Medical Holdings, Inc. — 23 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-12. Screen ADGM transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 6 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Cox James L — Director | 1 | — | — | 1 |
| GARDINER SANDRA A. — Director | 1 | — | — | 1 |
| MISHAN ORLY — Director | 1 | — | — | 1 |
| Mirsaeedi-Farahani Keyvan — Director | 1 | — | — | 1 |
| Moran Timothy P. — Director | 1 | — | — | 1 |
| Salmon Sean — Director | 1 | — | — | 1 |
Recent Form 4 filings — Adagio Medical Holdings, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-12 | 4 | Salmon Sean — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | Mirsaeedi-Farahani Keyvan — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | Cox James L — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | GARDINER SANDRA A. — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | MISHAN ORLY — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | Moran Timothy P. — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Kaster Deborah — Chief Financial Officer | Grant/award (A): 490,500 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Usen Todd — Chief Executive Officer, Director | Grant/award (A): 800,000 (derivative) @ $0 | EDGAR |
| 2025-12-18 | 4 | Kaster Deborah — Chief Financial Officer | Purchase (P): 15,000 @ $1.20 | EDGAR |
| 2025-12-15 | 4 | Usen Todd — Chief Executive Officer, Director | Purchase (P): 207,315 @ $1.09 | EDGAR |
| 2025-12-11 | 4 | Salmon Sean — Director | Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2025-10-22 | 4 | PERCEPTIVE ADVISORS LLC — Director, 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD — 10% owner EDELMAN JOSEPH — 10% owner | Purchase (P): 1,344,999 (derivative) @ $0.18 · Purchase (P): 1,344,999 (derivative) @ $0.18 · Purchase (P): 1,344,999 (derivative) @ $0.18 · Purchase (P): 2,190,496 (derivative) @ $1.60 | EDGAR |
| 2025-03-21 | 4 | Mirsaeedi-Farahani Keyvan — Director | Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2025-03-21 | 4 | MISHAN ORLY — Director | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2025-03-21 | 4 | Moran Timothy P. — Director | Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2025-03-21 | 4 | Cox James L — Director | Grant/award (A): 90,000 (derivative) @ $0 · Grant/award (A): 364,000 (derivative) @ $0 | EDGAR |
| 2025-03-21 | 4 | GARDINER SANDRA A. — Director | Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | PERCEPTIVE ADVISORS LLC — Director, 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD — Director, 10% owner EDELMAN JOSEPH — Director, 10% owner C2 Life Sciences LLC — Director, 10% owner | Grant/award (A): 64,167 | EDGAR |
| 2025-02-13 | 4 | Usen Todd — Chief Executive Officer, Director | Grant/award (A): 1,820,567 (derivative) @ $0 | EDGAR |
| 2024-10-01 | 4 | ARYA Sciences Holdings IV — 10% owner Stone Adam Leo — 10% owner ALTMAN MICHAEL SETH — 10% owner | Other (J): 3,501,600 | EDGAR |
| 2024-08-02 | 4 | Bergheim Hakon — Chief Operating Officer | Other (J): 7,539 · Grant/award (A): 1,000 (derivative) | EDGAR |
| 2024-08-02 | 4 | Cox James L — Director | Other (J): 36,698 | EDGAR |
| 2024-08-02 | 4 | BERGHEIM OLAV — CEO, Director | Other (J): 212,053 · Other (J): 22,081 | EDGAR |
Recent 8-K events — Adagio Medical Holdings, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-14 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-08-13 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-16 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-06-12 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-05-21 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-27 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-20 | 8-K | ? | EDGAR |
| 2026-04-08 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ADGM returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →